1. Khalil EAG; Homeida MMA; ALI HM; Suleiman S. Efficacy and tolerance of two brands of Praziquantel: Biltricide and Distocide. Sudan Med. J. 1986;vol. 23: (3-12)
2. Omer M; Gasim TA; Homeida MMA; Ali HM; Elwakil ES; GearyTG; Westerman RL; Jensen JB. A comparison of chloroquine and Clindamycin for the treatment of uncomplicated plasmodium falciparum malaria in the Sudan. Sudan Med. J. 1989;vol.
27:(1-4)
3. El Hassan AM, Fahal AH, El Hag IA, Khalil EAG. The Pathology of Mycetoma. Sudan Med. J. 1994;vol 32 (suppl): (23-45).
4. El Hassan AM, Zijlstra EE, Khalil EAG, Ghalib HW, Ismail. A.The spectrum of leishmania donovani infection in Salala village, Gedarif state: a longitudinal study. Sudan Med. J. 1995;vol 33 (1): 63-66.
5. Hashim FA, Khalil EAG, Ismail A, El Hassan AM. Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal Amphotericin B. Trans Roy Soc Trop Med Hyg (1995) 89,44.

6. Gaafar A, Ismail A, Kadaru AY, Hashim E, Khalil EAG, EL Hassan AM. Necrotizing and suppurative lymphadenitis in leishmania major infections. Tropical Medicine & International Health (1996), vol. 1(2): 243-250.
7. El Hassan AM, Meridith SEO, Yagi HI, Khalil EAG, Ghalib HW, Abbas K, Zijlstra EE, Kroon CCM, Ismail A. Sudan mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment. Trans Roy Soc Trop Med Hyg
(1995) 89,647 652.
8. El Hag IA, Fahal AH, Khalil EAG. (1996). Fine Needle Aspiration cytology of Mycetoma, Acta Cytologica; 40(3): 461-464.
9. Khalil EAG, Davidson RN, Nur NM, Zijlstra EE, El Hassan AM. Failure of a combination of Terbinafine and Itraconazole in the treatment of Post kala-azar dermal leishmaniasis in the Sudan. Transaction of the Royal Society of Tropical Medicine & Hygiene, (1996), 90: 187-188.
10. El Hassan AM, Kadaru AMY, Khalil EAG, Fadl A, El Hassan M. The Pathology of cutaneous leishmaniasis in the Sudan: a comparison with other geographical areas. Ann. Trop. Med. Parasitol. 1996; 90 (5): 485.
11. El Hassan AM, Hashim FA, Khalil EAG, Kadaru AMY, Ahmed AE, Elturabi H. Neurologic manifestation of visceral leishmaniasis. (1996). LabMedica International. 13:7-11.

12. Andersen K, Gasim S, Elhassan AM, Khalil EAG, Barker DC, Theander TG & Kharazmi A. (1997). Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from Sudan. Tropical Medicine & International Health, 2:440-445.
13. Ibrahim ME, Suleiman AM, Hashim FA, Khalil EAG, Evans D, Kharazmi A & Elhassan AM. (1997). Oronasal leishmaniasis caused by a parasite with an unusual isoenzyme profile. American Journal of Tropical Medicine & Hygiene,56(1):96-98.
14. Osman OF, Oskam L, Zijlstra EE, Kroon NCM, Schoone GJ, Khalil E.A.G.& Elhassan AM. (1997). Evaluation of the Polymerase Chain Reaction for the diagnosis of visceral leishmaniasis . Journal of Clinical Microbiology, 35:2454-2457.
15. Khalil E.A.G., Elhassan AM, Zijlstra EE, Hashim FA, Ibrahim ME, Ghalib HW & Ali MS. (1998). Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Annals of Tropical Medicine & Parasitology. 92(2): 151-158.
16. Khalil EAG, Hashim FA, Mustafa MD, Kordofani A, Satti M, El Hag IA, Elsafi S, Hag Ali M, Zijlstra EE, El Hassan AM, Ghalib HW, Ali MS. A comparative study comparing liposomal amphotericin B ( AmBisome ) and sodium stibogluconate in the treatment of kala-azar in the Sudan. East African Med. J.; 1998, 75(8):37-45.

17. Elhassan AM, Khalil E.A.G., Elsheikh EA, Zijlstra EE, Osman A. & Ibrahim ME. (1998). Post Kala-azar ocular leishmaniasis. Transaction of the Royal Society of Tropical Medicine & Hygiene, 92:177-179.
18. Osman OF, Oskam L, Kroon NC, Schoone Gj, Khalil EAG, Elhassan AM & Zijlstra EE. (1998). Use of PCR for diagnosis of post kala-azar dermal leishmaniasis. J Clin Microbiol, 36(6):1621-4.
19. Gasim S, Elhassan AM, Khalil EA, Ismail A, Kadaru AM, Kharazmi A, Theander TG. (1998). High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol; 111(1):64-9. Erratum in: Clin Exp Immunol; 112(3):547.
20. Saeed AM, Khalil EAG, Elhassan AM, Hashim FM, Elhassan AM, Fandrey J & Jelkman W. (1998). Serum erythropoietin concentration in anaemia of visceral leishmaniasis (kala-azar) before and during antimonial therapy. British Journal of Haematology, 100(4): 720-724.
21. Staalo, T., Khalil E.A.G., Elhassan I.M., Zijlstra E.E., Elhassan A.M., Giha H, Theander T. & Jacobsen P.H. (1998). Antibody reactivity to conserved linear epitopes of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). Immunology Letters, 60:121-126.
22. Zijlstra EE, Daifalla NS, Kager PA, Khalil, EAG, Reed SG & Ghalib HW. (1998). rK39 enzyme-linked immunosorbent assay for diagnosis of leishmania donovani infection. Clinical & Diagnostic Laboratory Immunology; 5(5): 717-720.
23. Ibrahim ME, Lambson B, Yousif AO, Deifalla NS, Alnaiem DA, Ismail A, Yousif H, Ghalib HW, Khalil EAG, Kadaro A, Barker DC, El Hassan AM. Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg 1999 Dec;61(6):941-4
24. Khalil EAG, Elsiddig, KE, Elsafi MEMO, El-Hag, Elkhidir IM, Suleiman G, Hussein AM, Ibrahim ME. & Elhassan A.M (2000). Supra-sternal tuberculous abscess: a report of three cases; Trans Roy Soc Trop Med Hyg; 94:1-3.
25. Gasim S, Elhassan AM, Kharazmi A, Khalil EAG, Ismail A, Theander TG.(2000). The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC). Clin Exp Immunol;119(3):523-529
26. Zijlstra EE, Khalil EAG, Kager P and Elhassan AM. (2000). Post kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol, 143(1):136-43.

27. Khalil EAG, Elhassan AM, Zisltra EE, Mukhtar MM, Ibrahim ME et al. (2000). Safety & Immunogenicity of an autoclaved L.major vaccine. East African Medical Journal, 77(9):468-70

.
28. Khalil EAG, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, Modabber F. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCGcontrolled
trial in Sudan. Lancet. 2000 Nov 4;356(9241):1565-9.
29. Zijlstra EE, Nur Y, Desjeux P, Khalil EAG, El-Hassan AM, Groen J. (2001). Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Tropical Medicine Inernationat Health;6(2):108-13.
30. Satti IN, Osman HY, Daifalla NS, Younis SA, Khalil EAG, Zijlstra EE, El Hassan AM, Ghalib HW.(2001). Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers. Vaccine. 2001 Feb 28;19(15-16):2100-6.
31. Cavanagh DR, Dobano C, Elhassan IM, Marsh K, El-Hassan A, Hviid L, Khalil EAG, Theander TG, Arnot DE, McBride JS. (2001). Differential patterns of human mmunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun; 69 (2) : 1207 –11.

32. El-Hassan AM. & Khalil EAG. (2001). The role of Post Kala-azar dermal leishmaniasis in the transmission of leishmania donovani infection. Tropical Medicine & International Health;6(9):743-744.
33. Khalil EAG, Zijlstra EE, Kager PA & El-Hassan AM. (2002). Epidemiology and clinical manifestations of L.donovani infection in two villages in an endemic area in eastern Sudan. Tropical Medicine & International Health; 7(1):35-44.
34. El-Hassan LA, Khalil EAG & Elhassan AM. (2002). Socio-cultural aspects of leprosy among the Masalit & Hawsa tribes in the Sudan. Leprosy Review; 73(1):20-8

.
35. Satti I, El-Hassan AM, Khalil EAG & Akuffo H. (2002). The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers. Transactions of the Royal Society of Tropical Meidicine & Hygiene;
96:565-567.
36. Musa AM, Khalil EAG, Raheem MA, Zijlstra EE, Ibrahim ME, Elhassan IM, Mukhtar MM & El-Hassan AM. (2002). The natural history of Sudanese post kalaazar dermal leishmaniasis: clinical, immunological prognostic features. Annals of Tropical Medicine & Parasitology, 96:765-72
37. Zijlstra EE, Musa AM, Khalil EAG, Elhassan IM & El-Hassan AM. (2003). Post Kala-azar dermal leishmaniasis. Lancet Infectious Diseases; 3:87-98.
38. Elsiddig K.E.; Khalil E.A.G.; Elhag I.A.; Elsafi M.E.M.O.; Suleiman G.M.; Elkhidir I.M.; Hussein A.M.; El-Hassan A.M. (2003). Granulomatous mammary disease: ten years experience with fine needle aspiration cytology. The International Journal of Tuberculosis and Lung Disease,; 7,(4): 365-369.
39. Mohamed HS, Ibrahim ME, Miller EN, Peacock CS, Khalil EAG, Cordel HJ, Howson JM, El-Hassan AM, Bereir RE, Blackwell JM. (2003). Genetic susceptibility to visceral leishmaniasis in the Sudan: linkage and association with IL-4 and IFNGR1. Genes & Immunity; 4:351-55.
40. Bereir REH, Mohamed HS, Seielstad M, El-Hassan AM, Khalil EAG, Peacock CS, Blckwell JM. & Ibrahim ME. (2003). Allele frequency and genotype distribution of polymorphisms within disease-related genes is influenced by ethnic population substructuring in Sudan. Genetica; 119: 57-63.
41. Kamil A.A., Khalil E.A.G., Musa A.M., Modabber F., Mukhtar M.M., Ibrahim M.E., Zijlstra E.E., Sacks D., Smith P.G., Zicker F & Elhassan A.M. (2003). Alumprecipitated autoclaved L.major plus BCG, a candidate vaccine for visceral leishmaniasis: safety, skin delayed hypersensitivity response and dose finding in healthy volunteers. Transactions of the Royal Society of Tropical Medicine & Hygiene; 97(3):365–368.

42. Abdo MG, Elamin WM, Khalil EAG, Mukhtar MM. (2003). Antimony-resistant L.dononvani in eastern Sudan: incidenc and in vitro colleration. East Mediterranean Health Journal. 9(4):837-43.
43. Mohamed HS, Ibrahim ME, Miller EN, White JK, Cordell HJ, Howson JM, Peacock CS, Khalil EAG, El-Hassan AM & Blackwell JM. (2004). SLC11A1 (Formerly NRAMP1) and susceptability to visceral leishmaniasis in the Sudan. Eurpean Journal of Human Genetics, 12:66-74.
44. Aljafari AS, Khalil EAG, Elsiddig KE, El-Hag IA, Ibrahim ME, Elsafi MEMO, Hussein AM, Elkhidir IM. Suleiman GS. & El-Hassan AM. (2004). Diagnosis of tuberculous lymphadenitis by FNAC, microbiological methods & PCR: a comparative study. Cytopathology, 15: 44-48.
45. Eman H. Khalifa, Babikir G. Kaballo, Salma M. Suleiman, Eltahir A.G.Khalil, Ahmed M.El-Hassan. (2004). Pattern of glomerulonephritis in Sudan: histopathological and immunofluorescence study. Saudi J of Kidney Disease and Transplantation; 15 (2):176-179.
46. Khalil EAG; Nahla B. Ayed; AM Musa; Ibrahim ME.; Mukhtar MM; Zijlstra EE; Elhassan IM; P.G.Smith; PM. Kieny; Ghalib HW; F.Zicker; Modabber F; Elhassan. AM. (2005). Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clinical & Experimental Immunology 140:349-353.

47. Elamin, E.M.; Guerbouj, S.; Musa, A.M.; Guizani, I.; Khalil, E.A.G.; Mukhtar, M.M.; Elkadaro, A.M.Y.; Mohamed, H.S.; Ibrahim, M.E.; Abdel Hamid, M.M.; El Azhari, M.; El Hassan A.M. (2005). Uncommon clinical presentations of cutaneous leishmaniasis in Sudan. Transactions of Royal Society of Tropical Medicine & Hygiene; 99:803-808.
48. Musa AM; Khalil EAG; Mahgoub FA, Elkadaru AMY & El Hassan AM. (2005). Efficacy of Liposomal amphotericin B (AmBisome) in the treatment of persistent Post kala-azar dermal leishmaniasis (PKDL). Annals of Tropical Medicine & Parasitology; 99:563-69.
49. Musa AM; Khalil EAG; Ismail A; Elhassan IM; Fesharki H; Khamesipour A; Modabber F; Zijlstra EE; & El-Hassan AM. (2005). Safety, immunogenicity and possible efficacy of immunochemotherapy of persistent post kala-azar dermal leishmaniasis (PKDL). Sudanese Journal of Dermatology; 3:62-72.
50. Sharief AH, Gasim Khalil EA, Theander TG, Kharazmi A, Omer SA, Ibrahim ME. (2006). Leishmania donovani: an in vitro study of antimony-resistant amphotericin Bsensitive isolates. Exp Parasitol. 2006 Dec;114(4):247-52. Epub 2006 May 23.
51. Ismail A; Khalil EAG; Musa AM; Elhassan IM; Ibrahim ME; Theander TG. & El- Hassan AM. (2006). The Pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: Does ultraviolet light (UVB) radiation play a role? Medical Hypothesis; 66:993-999.
52. Khalil EAG; Ahmed AE; Musa AM. & Muna H. Hussein. (2006). Antimony-induced cerebellar ataxia. Saudi Medical Journal;27:90-92.
53. Khalil EAG; Musa AM; Modabber F; El-Hassan AM. (2006). Safety & immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved L.major +BCG) in children: an extended Phase II study. Ann Trop Paediatr; 26(4):357-61.
54. Salih MA, Ibrahim ME, Blackwell JM, Miller EN, Khalil EA, ElHassan AM, Musa AM, Mohamed HS. (2007). IFN-γ and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan. Genes Immun. 2006 Jan;8(1):75-8. Epub 2006 Nov 30.
55. Miller EN, Fadl M, Mohamed HS, Elzein A, Jamieson SE, Cordell HJ, Peacock CS, Fakiola M, Raju M, Khalil EA, Elhassan A, Musa AM, Ibrahim ME, Blackwell JM. (2007). Y chromosome lineage- and village-specific genes on Chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan. PLoS Genet 3(5): e71. doi:10.1371/journal.pgen.0030071.
56. Ghada Sulaiman; EAG Khalil; IA El-Hag; KE Elsiddig; M EMO Elsafi; ASAAljafari; AA Elnour; AM Hussein; IM Elkhidir & AM El-Hassan (2007). Circulating Mycobacterium tuberculosis in patients with tuberculous lymphadenitis: a possible route of spead. East African Medical Journal; 84(1):3-7.
57. Kaballo BG, Khogali MS, Khalifa EH, Khalil EA, El-Hassan AM, Abu Aisha H. (2007). Patterns of Acute Renal Failure in a referral centre in Sudan: Excluding intensive care and major surgery patients. Saudi J Kidney Dis Transpl; 18(2):220-5.
58. NM Yousif; AM Musa; AM El-Hassan; EAG Khalil & IM Elhassan. (2007). Anti-Glucose-Regulated Protein 78 (GRP78) antibody response in Alum/ALM plus BCG vaccine, visceral leishmaniasis and Post Kala-azar Dermal Leishmaniasis patients. Sudan Journal of Medical Sciences (Sudan JMS); 2(3):175-178.
59. Sharief AH, Khalil EA, Omer SA, Abdalla HS. (2008). Innovative serum-free medium for in vitro cultivation of promastigote forms of Leishmania species. Parasitol Int. 57(2):138-42 2008 Oct 14 [Epub ahead of print]. doi:10.1016/j. parint.2007.10.003.
60. Musa AM; Khalil EAG; Mahgoub FA; Hassab Elgawi SH; Modabber F; Elkadaru AMY; Aboud MH; Noazin S; Ghalib HW. & El-Hassan AM. (2008). Immunochemotherapy of persistent post kala-azar dermal leishmaniasis: a novel approach of treatment. Transactions of Royal Society of Tropical Medicine & Hygiene; 102(1):58-63. Epub 2007 Oct 25.
61. Khalil EAG; Musa AM; Elgawi SH; Meshasha A; I Gamar Eldawla; MO Elhassan; KA Eljaleel; Younis BM; Elfaki MEE. & El-Hassan AM. (2008). Revival of a leishmaniasis focus in White Nile state, Sudan. Annals of Tropical Medicine & Parasitology. 102(1):79:80.
62. Elagib AH; Ahmed AE; Hussein A; Musa AM; Khalil EAG &El-hassan AM.(2008). Possible predisposing factors for thrombotic cerebrovascular accidents in Sudanese patients. Saudi Medical Journal; vol 29(20): 447-448.
63. Ismail WMA; Khalil EAG; Bygbjerg Ib C; Osman FM; Musa AM & El-Hassan AM. (2008). Coverage and efficacy of BCG vaccination in displaced populations: a measure of effectiveness of an Expanded Program of Immunization. Khartoum Medical Journal; 1(1): 30-33.
64. Habab M. Yassin; Abubakr M.A. Nasr & Eltahir A.G. Khalil. (2008). Mammalian conception disorders: immune concepts & alternative treatment options. Khartoum Medical Journal; 1:56-61.
65. Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine 2008;26:6759-67. Epub 2008 Oct 23.
66. Nimir AA, Khalil EA, Musa AM, Yassin HM, El-Hassan AM. (2009). Evaluation of the particle gel diffusion technique for the detection of haemoglobin S in Sudanese patients. Ann Clin Biochem; 46:114-6. Epub 2009 Jan 22.
67. Sassan Noazin, Ali Khamesipour, Lawrence H. Moulton, Marcel Tanner, Kiumarss Nasseri, Farrokh Modabber, Iraj Sharifi, E.A.G. Khalil, Ivan Dario Velez Bernal, Carlos M.F. Antunes, Peter G. Smith. (2009). Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis. Vaccine 27: 4747–4753. doi:10.1016/j. Vaccine. 2009.05.084.
68. Mugtaba EA Abdalsalam and Eltaher AG Khalil (2009). Immunophenotypic patterns of cord blood mononuclear cells in a cohort of Sudanese neonates: subtle markers of health and disease. Cytometry Part B: Clinical Cytometry, Volume 76B, Issue 6 (p
394).
69. Farouk, S; M.A. Salih, A.M. Musa, J.M. Blackwell, E.N. Miller, E.A. Khalil, A.M. El Hassan, M.E. Ibrahim, H.S. Mohamed (2010). Interleukin-10 Gene Polymorphisms and Development of Post Kala-azar Dermal Leishmaniasis in a Selected Sudanese Population. Public Health Genomics; 13(6):362-7. DOI: 10.1159/000272457: December 2009.
70. Musa AM, NoazinS, Khalil EAG, ModabberF (2010). Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration. Trans R Soc Trop Med Hyg; 104 (1): 1-2.
71. Niven A Salih, Ayman A Hussain, Ibrahim A Elmugtaba, Abeir M Elzein, Ibrahim M Elhassan, Eltahir AG Khalil, Hani B Ishag, Hiba S Mohamed, Dominic Kwiatkowski and Muntaser E Ibrahim. Loss of balancing selection in the beta S globin locus. BMC Medical Genetics 2010 Feb 3; 11:21. 2010, 11:21doi:10.1186/1471-2350-11-21.
72. Hamad SH; Khalil EAG; Musa AM; Younis BM; Elfaki MEE; El-Hassan AM. (2010). Genetic diversity of Leishmania donovani isolates from Sudan: PCR-based RAPD characterization. Experimental Parasitology; 125(4):389-93. Epub 2010 Mar 25.
73. Elnijoomi NAA; Musa AM; Younis BM; Elfaki MEE; El-Hassan AM & Khalil EAG. (2010). Surrogate markers of subtle renal injury in patients with visceral leishmaniasis. SJKDT; 21(5): 872-875.
74. Farahna M.; Bderi Sl; Khalid Sami; Idris M; Radhakrishna P; Khalil EA. (2010). Anti-plasmodial effects of Azadirachta indica in expreimental cerebral malaria: apoptosis of cerebellar Purkinji cells of mice as a marker. North Am J Med Scie; 2:516-523.
75. Musa AM, Younis B, Fadlalla A, Royce C, Balasegaram M, Wasunna M, Hailu A, Edwards T, Omollo R, Mudawi M, Kokwaro G, El-Hassan A, Khalil EAG 2010. Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study. PLoS Negl Trop Dis. 2010 Oct 26;4(10):e855.
76. Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tesfaye S, Makonnen E, Khalil EAG, Ahmed O, Fadlalla A, El-Hassan A, Raheem M, Mueller M, Koummuki Y, Rashid J, Mbui J, Mucee G, Njoroge S, Manduku V, Musibi A, Mutuma G, Kirui F, Lodenyo H, Mutea D, Kirigi G, Edwards T, Smith P, Muthami L, Royce C, Ellis S, Alobo M, Omollo R, Kesusu J, Owiti R, Kinuthia J; Leishmaniasis East Africa Platform (LEAP) group. Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis. 2010 Oct 26;4(10):e709.
77. SH Hamad; EAG Khalil; Musa AM : ME Ibrahim & AM EL-Hassan. (2010). In vitro induction of unresponsiveness to sodium stibogluconate in Leishmania donovani isolates from Sudan. KMJ; 3:416-419.
78. El-Sharief MMO; Abdelsaam MEA; Hassan A & Khalil EAG. (2010). Possible Roles for Nucleic Acids Amplification-based Techniques (NAT) in Blood Donor Screening in Sudan. KMJ; 3:440-443.
79. Omollo R, Alexander N, Edwards T, Khalil EA, Younis BM, Abuzaid AA, Wasunna M, Njoroge N, Kinoti D, Kirigi G, Dorlo TP, Ellis S, Balasegaram M, Musa AM. (2011). Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials. 2011 Jun 30;12(1):166. [Epub ahead of print]
80. Edwards T, Omollo R, Khalil EA, Yifru S, Musa B, Musa A, Wasunna M, Smith PG, Royce C, Ellis S, Balasegaram M, Hailu A. Single-dose Liposomal Amphotericin B (AmBisome(R)) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials. 2011 Mar 6;12 (1):66. [Epub ahead of print]
81. Tansy Edwards, Raymond Omollo, Eltahir AG Khalil, Sisay Yifru, Brima Musa, Ahmed Musa, Monique Wasunna, Peter G Smith, Catherine Royce, Sally Ellis. Manica Balasegaram, Asrat Hailu Single-dose Liposomal Amphotericin B (AmBisome(R)) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials 2011, 12:66 doi:10.1186/1745-
6215-12-66.
82. Khalil, EAG, Musa AM, Musa BY, Elfaki MEE, Zijlstra EE & Elhassan AM. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication. Trop Doct. 2011 Jul;41(3):139-40. Epub 2011 Jun 15.
83. Raymond Omollo, Neal Alexander, Tansy Edwards, Eltahir AG Khalil, Brima M Younis, Abuzaid A Abuzaid, Monique Wasunna, Njenga Njoroge, Dedan Kinoti, George Kirigi, Thomas Dorlo, Sally Ellis, Manica Balasegaram and Ahmed M Musa. (2011). Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary
visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials. 2011 Jun 30;12(1):166. [Epub ahead of print].
84. Fakiola M, Miller EN, Fadl M, Mohamed HS, Jamieson SE, Francis RW, Cordell HJ, Peacock CS, Raju M, Khalil EA, Elhassan A, Musa AM, Silveira F, Shaw JJ, Sundar S, Jeronimo SM, Ibrahim ME, Blackwell JM. (2011). Genetic and Functional Evidence Implicating DLL1 as the Gene That Influences Susceptibility to Visceral Leishmaniasis at Chromosome 6q27. J Infect Dis .;204(3):467-77.
85. Sara H Hassabelgawi; Ahmed M Musa; Eltahir AG Khalil; Tamrat Abebe, Brima M Younis; Mona EE Elthair; Ahmed M EL-Hassan; Asrat Hailu; Aldert Bart. (2011). Probable genetic hybrids between Leishmania species in Sudanese isolates. Journal of Microbiology and Antimicrobials; 3(6):142-145.
86. Khalil EAG; Elnour AA; Musa AM; Elagib AA; Hassab Elgawi SH & ELzaki KE (2011). Tuberculous Lymphadenitis: Skin Delayed-Type Hypersensitivity Reaction and Cellular Immune Responses. WAJM 2011; 30(3): 193–196.
87. Omer SA; Khalil EAG; Sharief AH; Ali AH. (2011). Pregnancy-associated Malaria in Sudan: Prevalence and possible risk factors. The open Tropical Medicine Journal; 4:6-10.
88. Elzubair AO, Abbas AA, Fadul MH, Modawi AK, Ali NMI, Jadain AFF, Ahmed NAA, Adam SYA, Ahmed NAM, Kairy AAA &Khalil EAG. (2012). Aflatoxin M1 in breast milk of nursing Sudanese mothers. Mycotoxin Res, DOI 10.1007/s12550-012-0127x.
89. Musa AM, Khalil EAG, Hailu A. et al. Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial. PloS Neglected Tropical Diseases 2012; 6: e1674.
90. Elfaki ME, Khalil EA, De Groot AS, Musa AM, Gutiérrez Núñez A, Younis BM, Salih KA, El-Hassan AM. Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines. Hum Vaccin Immunother. 2012 Aug 24;8(12). [Epub ahead of print].
91. Sara Noureldyme Mohamed, Eltahir Awad Gasim Khalil*, Ahmed Mudawi Musa, Brima Musa Younis, Samia Ali Omer, Abdalla Hassan Sharief & Ahmed Mohamed EL-Hassan (2012). Anti-Leishmania donovani antibodies enhance promastigotes internalization into host macrophage. Journal of Microbiology and Antimicrobials Vol. 4(7), pp. 110-114, December 2012. Available online http://www.academicjournals.org/JMA. DOI:10.5897/JMA11.047.
92. EL Hassan AM, EAG Khalil, Elamin WM, EL Hassan LAM, Ahmed ME, Musa AM. Misdiagnosis of Post-Kala-azar Dermal Leishmaniasis (PKDL). Journal of Tropical Medicine, Volume 2013. http://dx,doi.org/10.1155/2013/351579.
93. Eltahir Awad Gasim Khalil *§; Selma Abdelmoneim Khidir; Ahmed Mudawi Musa; Brema Younis Musa; Mona Elfaki Eltahir Elfaki; Abdelgadir Mohamed Yousif Elkadaru; Edward Zijlstra; Ahmed Mohamed El-Hassan. Post kala-azar dermal leishmaniasis: a paradigm of paradoxical immune reconstitution syndrome in non-HIV/AIDS patients. Journal of Tropical Medicine, Volume 2013. http://dx,doi.org/10.1155/2013/275253.
94. A M Musa, EAG Khalil, BM Younis, MEE Elfaki, MY Elamin, AOA Adam, HAA Mohamed, MMM Dafalla, AA Abuzaid, AM EL-Hassan. Treatment-Based Strategy for the Management of Post Kala-azar Dermal Leishmaniasis (PKDL) Patients in the Sudan. Volume 2013, Article ID 708391, 5 pages http://dx.doi.org/10.1155/2013/708391.
95. Shakak, AO; Salih KAM; Musa AM; Beshir AA; Idris FM; Ahmed AH, Elhassan AM & Khalil EAG. (2013). Possible risk factors of progression to overt diseases among individuals with Latent tuberculosis infection (LTBI) in Sudan. International Journal of Current Research; 5(5):1107-1110.
96. Abd Elrazig MH; Abd Elsalam ME; Musa AM; Khalil EAG. (2013). Frequency of BCR-ABL transcripts among Sudanese patients with persistent Myeloid leucocytosis: a diagnostic aide for chronic myeloid leukaemia in low income countries. International Journal of Current Research; 5(5):1291-1293.
97. Khalil EAG, El Hag IA, Elsiddig KE, Elsafi MEMO, Elfaki MEE, Musa AM, Musa BY, Elhassan AM. A clinical algorithm for triaging patients with significant lymphadenopathy in primary health care settings in Sudan. African Journal Primary Health Care Family Medicine. 2013; 5(1), Art. #435, 6 pages. http://dx.doi.org/10.4102/ phcfm.v5i1.435.
98. MEE Elfaki, EAG Khalil, AM Musa, BM Younis, Kerstin Muller, AM Elhassan, Rainer Blasczyk. HLA DRBI, DQBI and DQAI alleles’ frequencies in Nilo- Saharan and Fellata populations of Sudan: a molecular approach. (submitted).
99. MEE Elfaki, AM Musa, BM Younis, Kerstin Muller, Rainer Blasczyk. AM Elhassan, EAG Khalil. The Role of MHC Class II alleles in
protection/Susceptibility to visceral leishmaniasis in The Sudan. (submitted).
100. MEE Elfaki, EAG Khalil, AM Musa, BM Younis, Kerstin Muller, Rainer Blasczyk. AM Elhassan, AS DeGroot. In silico Prediction of Immunogenic T-cell epitopes as vaccine candidates for visceral Leishmaniasis. (submitted).
101. Wigdan M.A. Ismaiel, Eltahir A.G. Khalil, Faiza M. Osman1, Muzmil A Abdelraheem, Ahmed M. Musa, Ahmed M. El Hassan and Ib C. Bygbjerg. Health status of internally displaced people (IDP) in the Sudan: Children’s nutrition and morbidity as health indicators.(submitted).
102. Shakak, AO; Salih KAM; Musa AM; Beshir AA; Idris FM; Ahmed AH, Elhassan AM & Khalil EAG. Latent Tuberculosis infection in Northern Sudan: comparison between Tuberculin skin test (TST and Interferon-γ release asssay (IGRA). (Submitted).
103. Brema Musa Younis; Hatim Abd Alla Ahmed Mohamed; Mohamed Yassin Elamin; AbuBakr Osman Abdalla Adam; Mohamed Mustafa Mohamed Dafalla; Ahmed Mudawi Musa; Eltahir Awad Gasim Khalil; Ahmed Mohamed El-Hassan. Apparent Cure of Post Kala-Azar Dermal Leishmaniasis with Paromomycin/ Sodium stibogluconate Combination. (Submitted).
104. A M EL Hassan, A M Musa, W Elamin, M Yasein, M Ahmed, N EL Sheikh, O Osman, E A G Khalil. The role of Ultraviolet light (UVB) induced Treg cells in the pathogenesis of post Kala-azar dermal leishmaniasis. (Submitted).